· CORE DISCIPLINE
GDP

Good Distribution Practice

Supply-chain integrity, storage, and cold-chain control.

Browse all 13 GDP standards →Assess your quality system →

What this page does not claim

Educational orientation — not a determination of regulatory applicability, compliance, validation scope, or organizational approval.

WHAT IT GOVERNS

Good Distribution Practice governs the storage and transport of medicinal products through the supply chain (EU GDP 2013/C 343/01 and equivalents) — the part of the lifecycle after a product leaves the manufacturer and before it reaches the patient. Its job is to preserve the quality and integrity built at manufacture and to keep falsified medicines out of the legitimate chain.

WHY IT MATTERS

A perfectly manufactured product can still be ruined in distribution — a broken cold chain, a temperature excursion, or a falsified-medicine infiltration undoes everything upstream. GDP is where supply integrity is defended, and its failures translate directly into degraded product reaching patients or shortages when compliant supply is disrupted.

WHAT TO DO FIRST

  1. HOW-TO GUIDEHow to Assess a Temperature Excursion →Decide what happens to stock after an excursion, on evidence.
  2. TOOLCold-Chain MKT Calculator →Turn a logger trace into a mean kinetic temperature.
  3. HOW-TO GUIDEHow to Qualify a Cold Chain Shipping Lane →Qualify a lane before it carries product, not after an excursion.

KEY FOCUS AREAS

01

Temperature & cold-chain control

Qualified storage and transport with mapped temperatures, monitored conditions, and defined limits — so cold-chain and ambient products stay within their labelled storage range end to end.

02

Qualification of suppliers & customers

Trading only with authorised suppliers and customers, verifying licences, and applying due diligence that keeps the distribution network legitimate.

03

Transport & shipping validation

Validated shipping lanes and packaging that hold conditions through the real-world transport a product will actually experience, including worst-case seasons and routes.

04

Falsified-medicine safeguards

Controls against falsified medicines entering the supply chain — verification, tamper-evidence, and handling of suspected falsifications.

STANDARDS SPEQ DECODES · 13

Open the full library →
2013/C 343/01ECHIGH INSPECTION RISK
EU Guidelines on Good Distribution Practice of Medicinal Products
WHO TRS 957, Annex 5WHO
WHO Good Distribution Practices for Pharmaceutical Products
MHRA GDPMHRA
UK Good Distribution Practice (Rules & Guidance for Distributors)
21 CFR Part 1, Subpart LFDA
Foreign Supplier Verification Programs (FSVP)
DSCSA (FD&C Act §§581–585)FDAHIGH INSPECTION RISK
Drug Supply Chain Security Act
GS1 General SpecificationsGS1
GS1 General Specifications — identification keys, data attributes and barcodes
Del. Reg. (EU) 2016/161ECHIGH INSPECTION RISK
Safety Features on the Packaging of Medicinal Products (Falsified Medicines Directive)
2015/C 95/01EC
EU Guidelines on Good Distribution Practice of Active Substances for Medicinal Products for Human Use
USP <1079>USP
Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products
WHO TRS 961, Annex 9WHO
Model Guidance for the Storage and Transport of Time- and Temperature-Sensitive Pharmaceutical Products
Impl. Reg. (EU) 2021/1280EC
Good Distribution Practice for Active Substances Used as Starting Materials in Veterinary Medicinal Products
PDA TR No. 39PDA
Guidance for Temperature-Controlled Medicinal Products: Maintaining the Quality of Temperature-Sensitive Medicinal Products through the Transportation Environment
IATA TCR (14th ed., 2026)IATA
IATA Temperature Control Regulations (TCR)

WHAT INSPECTORS LOOK AT

  • Temperature mapping of storage areas and vehicles
  • Management of excursions — assessment, decision, and product disposition
  • Handling of returns, recalls, and suspected falsified products
  • Wholesale distribution authorization and qualification of trading partners

KEY REGULATORY BODIES

Derived from the 13 standards SPEQ decodes for this discipline.

RELATED DISCIPLINES

GMPGood Manufacturing PracticeQMSQuality Management SystemsGDocPGood Documentation Practice

SECTORS THAT OPERATE UNDER GDP

DistributionDistribution & LogisticsPackagingPackaging, Labeling & Serialization
TOPIC EXPLAINERS ACROSS THIS DISCIPLINE
14 total
Cold Chain & Temperature Control in Distribution →
How Good Distribution Practice keeps a medicine within its qualified temperature range from the factory to the patient — mapping, the qualified cold chain, and what an excursion actually means.
Serialization & Falsified Medicines →
How a unique identifier on every saleable pack, plus tamper-evidence and interoperable verification, keeps falsified product out of the legitimate supply chain — and why regulators specify the outcome while GS1 specifies the syntax.
Temperature Excursion Management →
Handling a temperature excursion in distribution — stability-budget assessment, quarantine, and the release-or-reject decision.
Transport Qualification in GDP →
Qualifying shipping lanes, packaging, and vehicles so medicines stay in condition from dispatch to delivery.
Returns & Recalls in Distribution →
How distributors handle returned medicines, execute recalls, and keep falsified product out of the legitimate supply chain.
Establishment Registration & Licensing →
The permissions the business actually runs on — registrations, manufacturing and wholesale licences, importer roles — and why they lapse quietly.
Supply Network Strategy & Resilience →
Qualification lead times mean an alternative source cannot be created during a disruption — you supply from the network you built.
Materials, Components & Packaging Controls →
A specification that omits an attribute the process depends on will be met by material that does not work — and the supplier will be right.
Quality & Technical Agreements →
It decides who does what when something goes wrong — written while nothing has.
Procurement & Contracting for Regulated Supply →
Procurement decisions create quality obligations that quality did not negotiate.
Shortage Prevention & Supply Continuity →
Most shortages trace to a single site or upstream supplier — which makes them foreseeable from the network map long before they occur.
Demand, Capacity & Scenario Planning →
Forecast error becomes either shortage or write-off — and the shortage side carries patient harm.
DSCSA: US Drug Supply Chain Security →
What the Drug Supply Chain Security Act requires of manufacturers, distributors and dispensers — product identifiers, tracing data, verification, and suspect and illegitimate product — and where the exemptions stand.
Veterinary Medicines: GMP and Pharmacovigilance →
How veterinary medicines are authorised, made, distributed, used and watched in the EU and US — and where human-medicine habits mislead.

GDP: frequently asked questions

Reference answers on Good Distribution Practice — what it governs, what regulations define it, and what it requires.

What is Good Distribution Practice (GDP)?

GDP governs the storage and transport of medicinal products through the supply chain — the part of the lifecycle after a product leaves the manufacturer and before it reaches the patient. Its job is to preserve the quality and integrity built at manufacture and to keep falsified medicines out of the legitimate chain.

What guideline governs GDP in the EU?

EU distribution is governed by the Guidelines on Good Distribution Practice of medicinal products for human use, 2013/C 343/01. Equivalent standards are published by other authorities. They cover temperature control, qualification of suppliers and customers, transport, and the handling of returns, recalls, and suspected falsifications.

What does GDP require for cold-chain products?

GDP requires qualified storage and transport with mapped temperatures, monitored conditions, and defined limits, so cold-chain and ambient products stay within their labelled storage range end to end. Shipping lanes and packaging must be validated against the real-world transport a product will experience, including worst-case seasons and routes.

THE FRAMEWORK

How SPEQ maps this discipline across the three layers →

FDA QMM

The maturity of the quality system behind this discipline →

PUT IT TO WORK

  1. HOW-TO GUIDEHow to Assess a Temperature Excursion →Decide whether product exposed to out-of-range temperature is still usable.
  2. HOW-TO GUIDEHow to Appoint a Responsible Person for Wholesale Distribution →Put a named, empowered individual behind a wholesale dealer authorisation.
  3. ASSESSBaseline your quality system →Twelve GxP domains, about ten minutes, free with an account.

A free account keeps what you save, remembers where you are across devices, and can send you the weekly regulatory briefing. Create a free account